SCHEMBL5497788

SCHEMBL5497788

O=C1C(c2ccccc2)=C(c2ccccc2)C(=O)c2ccccc21

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.65
NPSR1 Q6W5P4 4/20 0.65
HTT P42858 3/20 0.65
ALDH1A1 P00352 2/20 0.65
MITF O75030 1/20 0.65
P2RX7 Q99572 1/20 0.61
LMNA P02545 4/20 0.61
HSP90AA1 P07900 3/20 0.61
HSP90AB1 P08238 3/20 0.61
GAA P10253 1/20 0.61
TDP1 Q9NUW8 1/20 0.61
FGFR1 P11362 3/20 0.59
FGFR2 P21802 3/20 0.59
FGFR4 P22455 3/20 0.59
FGFR3 P22607 3/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
SMN1; SMN2 Q16637 3/20 0.59
XBP1 P17861 2/20 0.59
L3MBTL1 Q9Y468 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740371 0.95 FGFR1 (0.61) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL10502062 0.87 MAPT (0.53) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL16735433 0.84 FGFR1 (0.55) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL16735427 0.84 FGFR1 (0.55) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL22143430 0.84 FGFR1 (0.55) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL9695242 0.84 MAPT (0.61) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL16297081 0.84 MAPT (0.56) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL10068409 0.84 P2RX7 (0.74) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL13116693 0.84 IDO1 (0.56) MAPTNPSR1HTTALDH1A1MITF
SCHEMBL9627597 0.84 IDO1 (0.62) MAPTNPSR1HTTALDH1A1MITF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250312733-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX INC (US) 2025-10-09 US disclosed
US-12364949-B2 Method for electrochemical gas separation VERDOX, INC. (US) 2025-07-22 US disclosed
US-20240173668-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX, INC 2024-05-30 US disclosed
US-11931692-B2 Method for electrochemical gas separation VERDOX, INC (US) 2024-03-19 US disclosed
EP-4320660-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION Verdox, Inc. (US) 2024-02-14 EP disclosed
CN-117425989-A Method for electrochemical gas separation 沃道克斯公司 2024-01-19 CN disclosed
US-20230012689-A1 ELECTROACTIVE SPECIES AND METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX, INC 2023-01-19 US disclosed
US-20220339579-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION U.S. DEPARTMENT OF ENERGY 2022-10-27 US disclosed
WO-2022216355-A1 METHOD FOR ELECTROCHEMICAL GAS SEPARATION VERDOX, INC. (US) 2022-10-13 WO disclosed
CN-106575078-B Photosensitive composition, cured film and method for producing the same, touch panel and display device thereof, liquid crystal display device, and organic EL display device 富士胶片株式会社 2020-02-21 CN disclosed
US-20150073177-A1 METHOD FOR INHIBITING TRYPANOSOMA CRUZI HOWARD UNIVERRSITY (US) 2015-03-12 US disclosed
CN-103518262-A Flexible device manufacturing method and flexible device MATSUSHITA ELECTRIC INDUSTRIAL CO LTD 2014-01-15 CN disclosed
WO-2013016661-A1 METHOD FOR INHIBITING TRYPANSOMA CRUZI HOWARD UNIVERSITY (US) 2013-01-31 WO disclosed
CN-102405686-A Organic electroluminescent display panel, organic electroluminescent display device provided with same, and method for manufacturing organic electroluminescent display panel PANASONIC CORP 2012-04-04 CN disclosed
US-20080020421-A1 METHODS OF SCREENING AGENTS FOR CYTOTOXIC AND ANTIMICROBIAL ACTIVITY NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-01-24 US disclosed
EP-0999256-B1 COMPOUNDS FOR ORGANIC EL ELEMENT AND ORGANIC EL ELEMENT TDK CORP (JP) 2007-02-14 EP disclosed
US-6399223-B1 Compound for use in organic EL device and organic EL device TDK CORPORATION (JP) 2002-06-04 US disclosed
CN-1287655-A Driving apparatus and driving method of organic electroluminescent device TDK CORP (JP) 2001-03-14 CN disclosed
EP-0999256-A1 COMPOUNDS FOR ORGANIC EL ELEMENT AND ORGANIC EL ELEMENT TDK Corporation (JP) 2000-05-10 EP disclosed
CN-1048619-A The manufacture method of direct effect grand master pattern/pressing mold that light shows DU PONT (US) 1991-01-16 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150073177-A1 METHOD FOR INHIBITING TRYPANOSOMA CRUZI PCNA, NQO1, NQO2 MAPT 4851/4885NPSR1 4430/4885HTT 3841/4885
US-20230012689-A1 ELECTROACTIVE SPECIES AND METHOD FOR ELECTROCHEMICAL GAS SEPARATION LPO, SQOR, QSOX1 MAPT 3680/4885NPSR1 3182/4885HTT 3457/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.